Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Riamet Dispersible |
| Active Ingredients: | Artemether 20mg Lumefantrine 120mg |
| Dosage Form: | Dispersible tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Novartis Saglik ve Gida Urunleri Sanayi ve Ticaret AS, Istanbul, Turkey |
| Product: | Semglee |
| Active Ingredient: | Insulin glargine 100IU/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Viatris Limited |
| Manufacturer: | Biocon Sdn Bhd, Nusajaya, Malaysia |
Dated this 5th day of April 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).